Navigation Links
Spleen may be source of versatile stem cells

A year ago, Massachusetts General Hospital (MGH) researchers discovered that the spleen might be a source of adult stem cells that could regenerate the insulin-producing islets of the pancreas. In a follow-up to that unexpected finding, members of the same team now report that these potential adult stem cells produce a protein previously believed to be present only during the embryonic development of mammals. The finding both supports the existence of these splenic stem cells and also suggests they may be able to produce an even greater variety of tissues. The report appears in the January 19 issue of SAGE KE, an online resource on the science of aging from the publishers of the journal Science.

"There may be a previously undiscovered pocket of primitive stem cells in the spleen that are important for healing several types of damage or injury," says Denise Faustman, MD, PhD, director of the MGH Immunobiology Laboratory and senior author of the SAGE KE report. "If so, these cells could have much broader therapeutic applications than suggested by our earlier work." In 2001 Faustman's team found that a treatment designed to address the autoimmune reaction underlying type 1 diabetes actually cured the disease in diabetic mice. Late in 2003 they reported the mechanism behind the earlier discovery: cells from the spleens of donor mice - intended to train the diabetic animals' immune systems not to attack islet cells - were actually producing new islets. The result suggested that the adult spleen - previously regarded as playing a fairly minor role in regenerative medicine - might contain a population of potential islet stem cells. In their pursuit of that finding, the MGH researchers investigated the possible presence of a protein called Hox11 in these cells. In mammals, Hox11 is a controller of key steps in embryonic development - including the formation of the spleen - but it was not known to be present in adults under
'"/>

Source:Massachusetts General Hospital


Page: 1 2 3

Related biology news :

1. Poplar trees redirect resources in response to simulated attack
2. The BIOS Initiative - open source biotechnology is born
3. Microbial fuel cell: High yield hydrogen source and wastewater cleaner
4. Birds brains reveal source of songs
5. Edible bivalves as a source of human pathogens: signals between vibrios and the bivalve host.
6. Fats fate depends on its source
7. Amazon source of 5-year-old river breath
8. Hybrid grass may prove to be valuable fuel source
9. Seal rookeries could provide a reliable food source for endangered California condors, study finds
10. Microbiology text tells stories, offers online resources
11. Lactic acid not athletes poison, but an energy source - if you know how to use it

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Spleen may source versatile stem cells

(Date:11/19/2009)... of the last ice age, North America,s vast assembl...res as mammoths, mastodons, camels, horses, ground... slide to extinction. , And when their populatio...ge animals equaled or surpassed Africa,s wildlife-...el ecosystem emerged as broadleaved trees once kep...
(Date:11/19/2009)...he offspring of two inbred strains tend to be supe...gene-level variability that leads to this phenomen...t our ability to custom-tailor crops for specific ...sumption or high glucose content for biomass fuel....ce of the common corn strain B73, University of Mi...
(Date:11/19/2009)...iana Tech University has found that a naturally oc...against giant salvinia. , Giant salvinia is a no... sunlight penetration into bodies of water, alteri...s been reported that giant salvinia can double in ...fessor of biological sciences at Louisiana Tech, s...
Breaking Biology News(10 mins):After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2Microorganism may provide key to combating giant salvinia throughout Louisiana 2Severe COPD may lead to cognitive impairment 50929 1Severe COPD may lead to cognitive impairment 50929 2Severe COPD may lead to cognitive impairment 50929 3Independent Provider Sponsored Administrative Cost Trends Increase in 2008 as Ratios Decrease on Product Mix Change 50926 1Independent Provider Sponsored Administrative Cost Trends Increase in 2008 as Ratios Decrease on Product Mix Change 50926 2Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 1Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 2Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 3Detroit Medical Center to Partner With my1HIE 28R 29 and Link With United Physicians and Olympia Physician Groups 50922 4
...clinical trials have determined that milk thistle ... not have any significant influence on the course ...tis B or C liver disease. These findings are publ... , According to the previous studies, milk thistle...at protect against various hepatotoxins, including...
...ough the open state of a membrane-protein,s ion ch... Illinois at Urbana-Champaign to obtain a detailed...ment on the affinity of ionizable amino-acid resid...ec. 15 issue of Nature, are expected to be welcome...entalists and theoreticians, because they have pre...
...Primate Research Center at Oregon Health & Sci...e that appears to control how stem cells become va...icant implications for the study of Parkinson,s di...ditions or diseases that might be combated by repl... published in the current online edition of the me...
Other Biology News:New technique helps researchers determine amino-acid charge 2OHSU discovery sheds light into how stem cells become brain cells 2
(Date:11/20/2009)...R TOLEDO recently announced that a free webinar, &...g At-Line Particle Characterization”, will b... the application of in situ particle characterizat...timize a series of roller compaction runs while va...tion forces. , (PRWEB) No...
(Date:11/19/2009)...19 Dr. Mate Hidvegi, inventor of A...press release issued on November 17 by Biropharma ... false and self-serving statements about its U.S. ...i stated from his office in Budapest, Hungary: ,...does not apply to AveULTRA, www.aveultra.com , ...
(Date:11/19/2009)...ny, November 19 MONITORING FORCE G...h, 2009 Flibanserin in the,indication treatment-re...disease for orphan drug status designation with th...ed dyskinesia is a complication of the mainstay,tr...en to some of those,affected, since it may be disa...
(Date:11/19/2009)...ia, November 19 AFFiRiS AG will fo... candidate at an unexpectedly early,stage of devel...nter into,Phase II clinical trial early in 2010. T...e completion of two Phase I trials with the candid...ision on the first interim,analysis of the seconda...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...RNewswire-FirstCall/ -- Genesis,Pharmaceuticals En...is" or,the "Company"), a U.S. pharmaceutical compa...epublic of China, today announced the launch of it...ttp://www.genesispharmaceuticals.com ., The webs...rate history,current products and recent news. The...
...stems (http://www.altogen.com ),announced launch ...or use,in laboratories and research facilities for...laboratory methods used to introduce DNA and RNA m...kes it possible to cross the,cellular barriers and...,into the cells for research or therapeutic purpos...
...apeutics,Inc., (Nasdaq: NLTX ), announced today t...resent at the following upcoming investor conferen...Conference at 2:25 p.m. ET,in the Kennedy II room ...n,New York, NY., -- Lazard Capital Markets 5th An...esday, November 19, 2008 in the La Maisonette I ro...
Other Biology Technology:Genesis Pharmaceuticals Launches New Corporate Website 2Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent 2Nile Therapeutics to Present at Two Upcoming Investor Conferences 2
FlowTACS Flow Cytometry Apoptosis Detection Kit from R&D Systems
ImageQuant 300 from GE Healthcare, formerly Amersham Biosciences
Human Cytokine Antibody Array 1.1 (4) Kit, RayBio from Raybiotech, Inc.
Feline IL-12 / IL-23 p40, Unconjugated from R&D Systems
Biology Products: